Nmero Injection IP is antibiotic formulation which is administered intravenously for the treatment of pneumonia, meningitis, sepsis, & anthrax. After administration, it shows a complete 100% of bioavailability with an elimination half-life of about 1 hour. This medication is known to exert therapeutic effects by inhibiting the final step of transpeptidation resulting in inhibition of bacterial cell wall synthesis. This activity of Nmero Injection IP results in bacterial death at a good rate. It comprises meropenem as an active compound having molecular formula C17H25N3O5S with a molar mass of 383.464 g/mol.